Novartis (China)

683 papers and 39.6k indexed citations i.

About

In recent decades, authors affiliated with Novartis (China) have published 683 papers, which have received a total of 39.6k indexed citations. Scholars at this organization have produced 190 papers in Molecular Biology, 106 papers in Immunology and 97 papers in Oncology on the topics of Psoriasis: Treatment and Pathogenesis (45 papers), Asthma and respiratory diseases (34 papers) and Epigenetics and DNA Methylation (29 papers). Their work is cited by papers focused on Molecular Biology (19.2k citations), Immunology (5.6k citations) and Oncology (4.4k citations). Authors at Novartis (China) collaborate with scholars in China, United States and Switzerland and have published in prestigious journals including Nature, Cell and New England Journal of Medicine. Some of Novartis (China)'s most productive authors include Peter Atadja, R. You, Michaël Parmentier, Kristian Reich and Sylvia Zhao.

In The Last Decade

Fields of papers published by authors at Novartis (China)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Novartis (China) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Novartis (China)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Novartis (China). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis (China) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis (China) more than expected).

Rankless by CCL
2025